Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000805928-24-000016
Filing Date
2024-01-11
Accepted
2024-01-11 17:07:27
Documents
3
Period of Report
2024-01-01

Document Format Files

Seq Description Document Type Size
1 FORM 3 wk-form3_1705010833.html 3  
1 FORM 3 wk-form3_1705010833.xml 3 3782
2 EX-24 poakemp_jx2024-01.htm EX-24 4310
3 poakemp_jx2024-01001.jpg GRAPHIC 239755
  Complete submission text file 0000805928-24-000016.txt   340059
Mailing Address 13631 PROGRESS BLVD. SUITE 400 ALACHUA FL 32615
Business Address 13631 PROGRESS BLVD. SUITE 400 ALACHUA FL 32615 (386) 462-6817
Axogen, Inc. (Issuer) CIK: 0000805928 (see all company filings)

EIN.: 411301878 | State of Incorp.: MN | Fiscal Year End: 1231
SIC: 3845 Electromedical & Electrotherapeutic Apparatus
(CF Office: 08 Industrial Applications and Services)

Mailing Address 13631 PROGRESS BLVD., SUITE 400 ALACHUA FL 32615
Business Address
Kemp Jens (Reporting) CIK: 0002007485 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36046 | Film No.: 24529899